| Identification | Back Directory | [Name]
Propanoic acid, 2,2-dimethyl-, 4-[[[9-[6-[[[chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl ester | [CAS]
1155309-89-9 | [Synonyms]
O6-(p-tolyl pivalate)-N2-PhAc protected G PMO Monomer
6-(6-oxo-2-(2-phenylacetamido)-1H-purin-9(6H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate
Propanoic acid, 2,2-dimethyl-, 4-[[[9-[6-[[[chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl ester | [Molecular Formula]
C51H53ClN7O7P | [MOL File]
1155309-89-9.mol | [Molecular Weight]
942.44 |
| Hazard Information | Back Directory | [Uses]
Activated DPG Subunit is a biochemical reagent used as a pharmaceutical intermediate. It is used as a starting material for the synthesis of PMO in the preparation of therapeutic treatments for muscular dystrophy. |
|
|